The VALidity Podcast

Retatrutide Explained | Peptide Series Pt. 1

Valentina Rodriguez

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 33:15

Send us Fan Mail

Welcome to Part 1 of our Peptide Series, where we break down the science behind today’s most talked-about compounds–starting with retatrutide.


In this episode, we dive into the mechanism of action of retatrutide, the first GLP-1, GIP, and glucagon triple agonist, and why it represents a major shift in obesity pharmacology.


We cover:

  • What GLP-1, GIP, and glucagon receptors actually do
  • How retatrutide drives satiety, insulin signaling, and energy expenditure simultaneously
  • Why adding glucagon changed the game
  • A clear breakdown of the clinical trial data so far
  • How retatrutide compares to current drugs like semaglutide and tirzepatide


This episode is your mechanism-first foundation for understanding where peptide-based fat loss is headed.


1:1 COACHING:

  • email: vallfittcoaching@gmail.com


SHOP MY NEW 'NUTRITION NAVIGATED' E-BOOK!


STRENGTH & HYPERTROPHY TRAINING PROGRAM: 


MY SOCIALS:

  • IG:@Vallfitt_ifbbpro
  • Tiktok: @Vallfitt
  • YouTube: VallFitt


CONTACT ME:


STUDIES/CLINICAL TRIALS: 

  • PMID: 37366315
  • PMID: 37385280
  • PMID: 41090431
  • PMID: 38367045

Support the show